Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: The TIPTOP trial

European Heart Journal

Volumn 35, Issue 3, 2014, Pages 184-191

  Cerisano, Giampaolo ^a   Buonamici, Piergiovanni ^a   Valenti, Renato ^a   Sciagrà, Roberto ^a   Raspanti, Silvia ^a   Santini, Alberto ^a   Carrabba, Nazario ^a   Dovellini, Emilio Vincenzo ^a   Romito, Roberta ^b   Pupi, Alberto ^a   Colonna, Paolo ^b   Antoniucci, David ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Echocardiography; Myocardial infarction; Remodelling

Indexed keywords

DOXYCYCLINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT DURATION;

ECHOCARDIOGRAPHY; MYOCARDIAL INFARCTION; REMODELLING;

ADULT; AGED; ANALYSIS OF VARIANCE; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; DISEASE PROGRESSION; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84892682128     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht420     Document Type: Article

References (39)

1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling: concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000;35:269-282.
2. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, Antoniucci D. Left ventricular remodeling after primary coronary angioplasty: pattern of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351-2357.
3. Jugdutt BI. Ventricular remodeling after myocardial infarction and the extracellular collagen matrix. When is enough enough? Circulation 2003;108:1395-1403.
4. Spinale FG, Coker ML, Krombach SR, Mukherjee R, Hallak H, Houck WV, Clair MJ, Kribbs SB, Johnson LL, Peterson JT, Zile MR. Matrix metalloproteinase inhibition duringthe development of congestive heart failure: effectson left ventricular dimensions and function. Circ Res 1999;85:364-376.
5. Heymans S, Luttum A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dsyprsin GD, Cleutjens JP, Shipley M, Angelillo A, Evi M, Nube O, Baker A, Keshet E, Lupu F, Herger JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases pre-ventscardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-1142.
6. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y. Targeted selection or pharmacological inhibition of MMP-2 prevents cardiac rupture after myo-cardial infarction in mice. J Clin Invest 2005;115:599-609.
7. Mukherjee R, Widener CE, Brinsa TA, Dowdy KB, Scott AA, Sample JA, Hendrick JW, Escobar GP, Joffs C, Lucas DG, Zile MR, Spinale FG. Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 2003;107: 618-625.
8. Kandasamy AD, Chow AK, Ali MA, Schulz R. Matrix metalloproteinase-2 and myo-cardial oxidative stress injury: beyond the matrix. Cardiovasc Res 2010;85:413-423.
9. Ali MA, Cho WJ, Hudson B, Kassiri Z, Henk G, Schulz R. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation 2010;122:2039-2047.
10. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R. Matrix metalloproteinase-2 contributes to ischemia/reperfusion injury in the heart. Circulation 2000;101:1833-1839.
11. Golub LM, Ciancio S, Ramamamurthy NS, Leung M, McNamara TF. Low-dosedoxy-cycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-330.
12. Modrak JB, Rovang KS. Estimation of infarct size by determination of myocardial 3H-tetracycline accumulation in the coronary ligated rat. Res Commun Chem Pathol Pharmacol 1981;34:149-152.
13. Griffin MO, Fricovsky E, Ceballos G, Villarreal FJ. Tetracycline: a pleiotropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 2010;539:C539-C548.
14. Ducharme A, Frantz S, Aikava M, Rabkin E, Lindsey M, Rodhe LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myo-cardial infarction. J Clin Invest 2000;106:55-62.
15. Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, Clark LL, Stround RE, Corn C, Finklea L, Zile MR, Spinale FG. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 2006;114:1020-1027.
16. Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, Squire LB. Plasma matrix metalloproteinase-9 and left ventricular remodeling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 2007;28:711-718.
17. Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, Covell J. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 2003;108:1487-1492.
18. Garcia RA, Go KV, Villarreal FJ. Effects of timed administration of doxycycline or methylprednisolone on post-myocardial infarction remodeling inflammation and left ventricular remodeling in the rat heart. Mol Cell Biochem 2007;300: 159-169.
19. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. Intracellular actions of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002;106:1543-1549.
20. Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, Baxter BT. Doxycycline in patients with abdominal aneurysms andin mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 2002;35: 923-929.
21. Schröder R, Dissmann R, Brüggemann T, Wegscheider K, Linderer T, Tebbe U, Neuhaus KL. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with AMI. J Am Coll Cardiol 1994;24:384-391.
22. Cerisano G, Bolognese L, Carrabba N, Buonamici P, Santoro GM, Antomiucci D, Santini A, Moschi G, Fazzini PF. Doppler-derived mitral deceleration time. An early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction. Circulation 1999;99:230-236.
23. Colonna P, Cadeddu C, Montisci R, Ruscazio M, Chen LJ, Onnis E, Meloni L, Iliceto S. Post-infarctionmicrovascular integrity predicts myocardial viability and left ventricular remodeling after primary coronary angioplasty. Astudy performed with intravenous myocardial contrast echocardiography. Ital Heart J 2002;3:506-513.
24. 99mTc- sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 2004;31:969-974.
25. Hudson MP, Armstrong PW, Ruzyllo W, Brun J, Cusmano L, Krzeski P, Lyon R, Quinones M, Theroux P, Sydlowski D, Kim HE, Garcia MJ, Jaber WA, Weaver WD. Effect of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction. Results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) Trial. J Am Coll Cardiol 2006;48:15-20.
26. Yabrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, hendrick JW, Dowdy KB, McLean JE, Spinale FG. Selective targeting and timing of matrix metallo-proteinase inhibition in post-myocardial infarction remodeling. Circulation 2003;108: 1753-1759.
27. Spinale FG, Escobar CP, Hendrick JF, Clark LL, Camens SS, Mingoia JP, Squires CG, Stroud RE, Ikonomidis JS. Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival. J Pharmacol Exp Ther 2006;318:966-973.
28. Bujak M, Frangogiannis NG. The role of interleukine-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp 2009;57:165-176.
29. Abbate A, Salloum F, Vecile E, Das A, Hoke N, Straino S, Biondi-Zoccai GGL, Houser J, Qureshi I, Ownby E, Giustini E, Biasucci L, Severino A, Capogrossi M, Vetrovec G, Crea F, Baldi A, Kukreia R, Dobrina A. Ankinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocar-dial infarction. Circulation 2008;117:2670-2683.
30. Bujak M, Dobaczewsky M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG. Interleukin-1 receptor type 1 signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 2008;173:57-67.
31. Popović AD, Nesković AN, Babić R, Obradović V, Bozinović L, Marinković J, Lee JC, Tan M, Thomas JD. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up. Circulation 1994;90:800-807.
32. Mollema SA, Liem SS, Suffoletto MS, Bleeker GB, van der Hoeven BL, van de Veire NR, Boersma E, Holman ER, van der Wall EE, Schalij MJ, Gorcsan J III, Bax JJ. Left ventricular dyssynchrony acutely after myocardial infarction predicts left ventricular remodeling. J Am Coll Cardiol 2007;50:1532-1540.
33. Galcerá-Tomás J, Castillo-Soria FJ, Villegas-García MM, Florenciano-Sánchez R, Sánchez-Villanueva JG, de La Rosa JA, Martínez-Caballero A, Valentí-Aldeguer JA, Jara-Pérez P, Párraga-Ramírez M, López-Martínez I, Iñigo-García L, Picó-Aracil F. Effects of early use of atenolol or captopril on infarct size and ventricular volume: a double-blind comparison in patients with anterior acute myocardial infarction. Circulation 2001;103:813-819.
34. Abbate A, Kontos MC, Grizzard JD, Biondi-Zoccai GGL, Van Tassel BW, Robati R, Roach LM, Arena RA, Roberts CS, Varma A, Gelwix CC, Salloum FN, Hastillo A, Dinarello CA, Vetrovec GW the VCU-ART Investigators. Interleukin-I blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling trial [VCU-ART] pilot study). Am J Cardiol 2013;111:1394-1400.
35. Donato M, D'Annunzio V, Buchholz B, Miksztowicz V, Carrion CL, Valdez LB, Zaobornyj T, Schreier L, Wikinski R, Boveris A, Berg G, Gelpi J. Role of matrix metalloproteinase-2 in the cardioprotective effect of ischemic postconditioning. Exp Physiol 2011;95:274-281.
36. Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther 2005;27:1329-1342.
37. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012;33:2569-2619.
38. Van de Werf F, Bax J, Betriu A, Blömstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction ofthe European Societyof Cardiology. Eur Heart J 2008;29:2909-2945.
39. Gibbons RJ. Tc-99mSPECT sestamibifor the measurementofinfarctsize. JCardiovasc Pharmacol Ther 2011;16:321-331.